HomeHealthWest to Participate in Upcoming Investor Conference

West to Participate in Upcoming Investor Conference

Published on

<br /> West to Participate in Upcoming Investor Conference<br />

PR Newswire



EXTON, Pa.


,


Sept. 8, 2022


/PRNewswire/ —

West Pharmaceutical Services, Inc.

(NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will participate in the Bank of America Global Healthcare Conference taking place

September 15, 2022

, in

London, UK

, at

1:20 pm

British Summer Time (

8:20 am EDT

).

A live audio webcast will be available in the “Investors” section of the Company’s website at

www.westpharma.com

. Replay of the webcasts will be available for approximately 90 days after the events.


About West

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With approximately 10,000 team members across 50 sites worldwide, West helps support our customers by delivering over 45 billion components and devices each year.

Headquartered in

Exton, Pennsylvania

, and in business for nearly a century, West in its fiscal year 2021 generated

$2.83 billion

in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor’s 500 index. For more information, visit

www.westpharma.com

.


All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.

Cision
View original content to download multimedia:

https://www.prnewswire.com/news-releases/west-to-participate-in-upcoming-investor-conference-301619849.html

SOURCE West Pharmaceutical Services, Inc.

rt West to Participate in Upcoming Investor Conference

Featured image: Megapixl © Noipornpan

Disclaimer

Latest News

Aetna 2023 Medicare plans put money back in members’ pockets

Aetna 2023 Medicare plans put money back in...

European Medicines Agency Accepts Astellas’ Marketing Authorization Application for Fezolinetant

European Medicines Agency Accepts Astellas' Marketing Authorization Application...

Biogen Announced EMA Filing Acceptance of BIIB800, A Biosimilar Candidate Referencing RoACTEMRA® (tocilizumab)

CAMBRIDGE, Mass., Sept. 30, 2022 (GLOBE NEWSWIRE) -- ...

Q&M Group awards 7 dentists with Performance Shares,12-year Service Agreements, and a Private Placement

Q&M Group awards 7 dentists with Performance Shares,12-year...

More like this

Numinus to Participate in the Cantor Neurology and Psychiatry Conference on October 6-7, 2022

VANCOUVER, BC, Sept. 29, 2022 - Numinus Wellness Inc. ("Numinus" or the "Company")(TSX:NUMI)(OTCQX:NUMIF), a mental...

Illumina Unveils Revolutionary NovaSeq X Series to Rapidly Accelerate Genomic Discoveries and Improve Human Health

Illumina Unveils Revolutionary NovaSeq X Series to Rapidly...

AbbVie Highlights Robust Gastroenterology Portfolio with New Data in Crohn’s Disease and Ulcerative Colitis at the UEG Week 2022

AbbVie Highlights Robust Gastroenterology Portfolio with New Data...

Cosmos Health Enters into Letter of Intent for the Acquisition of ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.

CHICAGO, IL / ACCESSWIRE / September 28, 2022 / Cosmos Holdings d/b/a Cosmos Health,...

Moderna Creates New Executive Committee Role Ahead of New Product Launches

Juan Andres Appointed to President, Strategic Partnerships and Enterprise ExpansionJerh Collins Joins Moderna as...